Home NDC 68001-348 GEMCITABINE
Product NDC 68001-348
11-digit product format 680010348
Labeler code 68001
Product ID 68001-348_830c5aa5-79d2-4342-9d53-070bfd7ab05c
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name GEMCITABINE
Dosage form INJECTION, SOLUTION
Route INTRAVENOUS
Labeler BluePoint Laboratories
Application NDA209604
Marketing category NDA
Marketing start 2018-05-25
Marketing end 0000-00-00
Substance GEMCITABINE HYDROCHLORIDE
Active strength 100 mg/mL
Pharmacologic classes Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
NDC exclude flag No
Listing certified through 2020-12-31
Current FDA listing Historical FDA.report record
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N209604-001 GEMCITABINE HYDROCHLORIDE GEMCITABINE HYDROCHLORIDE 200MG/2ML (100MG/ML) SOLUTION / INTRAVENOUS RLD 2017-08-03 N209604-002 GEMCITABINE HYDROCHLORIDE GEMCITABINE HYDROCHLORIDE 1GM/10ML (100MG/ML) SOLUTION / INTRAVENOUS RLD 2017-08-03 N209604-003 GEMCITABINE HYDROCHLORIDE GEMCITABINE HYDROCHLORIDE 1.5GM/15ML (100MG/ML) SOLUTION / INTRAVENOUS RLD 2017-08-03 N209604-004 GEMCITABINE HYDROCHLORIDE GEMCITABINE HYDROCHLORIDE 2GM/20ML (100MG/ML) SOLUTION / INTRAVENOUS RLD 2017-08-03
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 176 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 N209604-001 GEMCITABINE HYDROCHLORIDE 200MG/2ML (100MG/ML) SOLUTION / INTRAVENOUS RLD 2017-08-03 c2088c7a36db…2026-10-15 13:18:30 2026-09 N209604-002 GEMCITABINE HYDROCHLORIDE 1GM/10ML (100MG/ML) SOLUTION / INTRAVENOUS RLD 2017-08-03 c2088c7a36db…2026-10-15 13:18:30 2026-09 N209604-003 GEMCITABINE HYDROCHLORIDE 1.5GM/15ML (100MG/ML) SOLUTION / INTRAVENOUS RLD 2017-08-03 c2088c7a36db…2026-10-15 13:18:30 2026-09 N209604-004 GEMCITABINE HYDROCHLORIDE 2GM/20ML (100MG/ML) SOLUTION / INTRAVENOUS RLD 2017-08-03 c2088c7a36db…2026-09-14 22:38:34 2026-08 N209604-001 GEMCITABINE HYDROCHLORIDE 200MG/2ML (100MG/ML) SOLUTION / INTRAVENOUS RLD 2017-08-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209604-002 GEMCITABINE HYDROCHLORIDE 1GM/10ML (100MG/ML) SOLUTION / INTRAVENOUS RLD 2017-08-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209604-003 GEMCITABINE HYDROCHLORIDE 1.5GM/15ML (100MG/ML) SOLUTION / INTRAVENOUS RLD 2017-08-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209604-004 GEMCITABINE HYDROCHLORIDE 2GM/20ML (100MG/ML) SOLUTION / INTRAVENOUS RLD 2017-08-03 84e616aacf4f…2026-08-18 06:07:40 2026-07 N209604-001 GEMCITABINE HYDROCHLORIDE 200MG/2ML (100MG/ML) SOLUTION / INTRAVENOUS RLD 2017-08-03 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209604-002 GEMCITABINE HYDROCHLORIDE 1GM/10ML (100MG/ML) SOLUTION / INTRAVENOUS RLD 2017-08-03 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209604-003 GEMCITABINE HYDROCHLORIDE 1.5GM/15ML (100MG/ML) SOLUTION / INTRAVENOUS RLD 2017-08-03 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209604-004 GEMCITABINE HYDROCHLORIDE 2GM/20ML (100MG/ML) SOLUTION / INTRAVENOUS RLD 2017-08-03 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N209604-001 GEMCITABINE HYDROCHLORIDE 200MG/2ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-08-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209604-002 GEMCITABINE HYDROCHLORIDE 1GM/10ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-08-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209604-003 GEMCITABINE HYDROCHLORIDE 1.5GM/15ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-08-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209604-004 GEMCITABINE HYDROCHLORIDE 2GM/20ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-08-03 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209604-001 GEMCITABINE HYDROCHLORIDE 200MG/2ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-08-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209604-002 GEMCITABINE HYDROCHLORIDE 1GM/10ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-08-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209604-003 GEMCITABINE HYDROCHLORIDE 1.5GM/15ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-08-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209604-004 GEMCITABINE HYDROCHLORIDE 2GM/20ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-08-03 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N209604-001 GEMCITABINE HYDROCHLORIDE 200MG/2ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-08-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209604-002 GEMCITABINE HYDROCHLORIDE 1GM/10ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-08-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209604-003 GEMCITABINE HYDROCHLORIDE 1.5GM/15ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-08-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209604-004 GEMCITABINE HYDROCHLORIDE 2GM/20ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-08-03 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209604-001 GEMCITABINE HYDROCHLORIDE 200MG/2ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-08-03 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209604-002 GEMCITABINE HYDROCHLORIDE 1GM/10ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-08-03 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209604-003 GEMCITABINE HYDROCHLORIDE 1.5GM/15ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-08-03 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209604-004 GEMCITABINE HYDROCHLORIDE 2GM/20ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-08-03 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209604-001 GEMCITABINE HYDROCHLORIDE 200MG/2ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-08-03 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209604-002 GEMCITABINE HYDROCHLORIDE 1GM/10ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-08-03 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209604-003 GEMCITABINE HYDROCHLORIDE 1.5GM/15ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-08-03 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209604-004 GEMCITABINE HYDROCHLORIDE 2GM/20ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-08-03 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209604-001 GEMCITABINE HYDROCHLORIDE 200MG/2ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-08-03 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209604-002 GEMCITABINE HYDROCHLORIDE 1GM/10ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-08-03 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209604-003 GEMCITABINE HYDROCHLORIDE 1.5GM/15ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-08-03 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209604-004 GEMCITABINE HYDROCHLORIDE 2GM/20ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-08-03 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209604-001 GEMCITABINE HYDROCHLORIDE 200MG/2ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-08-03 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209604-002 GEMCITABINE HYDROCHLORIDE 1GM/10ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-08-03 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209604-003 GEMCITABINE HYDROCHLORIDE 1.5GM/15ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-08-03 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209604-004 GEMCITABINE HYDROCHLORIDE 2GM/20ML (100MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-08-03 2680178bc6a6…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 68001-348-36 GEMCITABINE 10 mL in 1 VIAL, MULTI-DOSE INJECTION, SOLUTION 10 5 68001-348-36 GEMCITABINE 1 in 1 CARTON INJECTION, SOLUTION 1 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 68001-348 GEMCITABINE INJECTION, SOLUTION [BLUEPOINT LABORATORIES] 5 Legacy NDC, 2 package rows 20230912_4031017d-d768-46de-8081-476bcb883f5e.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 68001-348-36 68001034836 1 VIAL, MULTI-DOSE in 1 CARTON (68001-348-36) > 10 mL in 1 VIAL, MULTI-DOSE 2018-05-25 0000-00-00 No No Current